LYTROMBA
H. Lundbeck A/S
Application Filed: 2014-05-08
Trademark Application Details
IR CANCELLED; US REGISTRATION CANCELLED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79152570 |
| Registration Number | 4753858 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | H |
| Attorney Name | Claudia A. Smith |
| Attorney Docket Number | 1101391-0107 |
| Law Office Assigned | L60 |
| Employee Name | LAVACHE, LINDA M |
Timeline
| 2014-05-08 | Application Filed |
| 2015-03-31 | Published for Opposition |
| 2015-06-16 | Location: PUBLICATION AND ISSUE SECTION |
| 2015-06-16 | Trademark Registered |
| 2019-03-28 | Cancelled |
| 2019-03-28 | Status: Dead/Cancelled |
| 2019-04-13 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  H. Lundbeck A/S |
| Entity Statement | aktieselskap (a/s) |
| Address | Ottiliavej 9 DK-2500 Valby DK |
| Legal Entity Type | |
| Legal Entity State | DK |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, preparations for the treatment and prevention of brain and central nervous system diseases and disorders; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, mood disorder, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, stroke, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agents |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2014-10-02 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-10-03 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2014-10-03 | 3 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2014-10-07 | 4 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2014-10-07 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2014-10-08 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2014-10-08 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2014-10-08 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2014-10-24 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-01-23 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-01-23 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-01-24 | 12 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2015-01-28 | 13 CNEA R:Renewal |
| EXAMINER'S AMENDMENT ENTERED | 2015-01-28 | 14 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-01-28 | 15 CNSA O:Outgoing Correspondence |
| EXAMINERS AMENDMENT MAILED | 2015-01-29 | 16 CNEA O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2015-01-29 | 17 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2015-01-29 | 18 ARAA I:Incoming Correspondence |
| CORRECTION TRANSACTION RECEIVED FROM IB | 2015-02-06 | 19 CRCV M: |
| CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | 2015-02-13 | 20 CORR I:Incoming Correspondence |
| ASSIGNED TO LIE | 2015-02-16 | 21 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-02-21 | 22 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-03-11 | 23 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2015-03-18 | 24 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2015-03-18 | 25 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2015-03-31 | 26 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-03-31 | 27 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2015-04-04 | 28 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2015-06-16 | 29 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2015-09-16 | 30 FICR P: |
| FINAL DISPOSITION PROCESSED | 2015-10-08 | 31 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2015-10-08 | 32 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2015-10-24 | 33 FINO P: |
| DEATH OF INTERNATIONAL REGISTRATION | 2019-04-12 | 34 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | 2019-04-12 | 35 DENC E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 